Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4227)
All Articles published online
|
May 7, 2007 (publication date) through May 6, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Dubuisson J. Hepatitis C virus proteins. World J Gastroenterol 2007; 13(17): 2406-2415 [PMID: 17552023 DOI: 10.3748/wjg.v13.i17.2406] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v13/i17/2406.htm |
| Number | Citing Articles |
| 1 |
William M. Kamp, Cortlandt M. Sellers, Stacey Stein, Joseph K. Lim, Hyun S. Kim. Direct-Acting Antivirals Improve Overall Survival in Interventional Oncology Patients with Hepatitis C and Hepatocellular Carcinoma. Journal of Vascular and Interventional Radiology 2020; 31(6): 953 doi: 10.1016/j.jvir.2019.12.809
|
| 2 |
Roopa Rai, Jerome Deval. New opportunities in anti-hepatitis C virus drug discovery: Targeting NS4B. Antiviral Research 2011; 90(2): 93 doi: 10.1016/j.antiviral.2011.01.009
|
| 3 |
Ivana Mikolasevic, Tajana F. Kanizaj, Dorotea Bozic, Petra Puz, Sanja S. Shapeski, Zeljko Puljiz, Delfa Radic-Kristo, Milos Lalovac, Maja Mijic, Bozena Delija, Toni Juric, Ivan Bogadi, Lucija Virovic-Jukic. Metabolism of Direct-acting Antiviral Agents (DAAs) in Hepatitis C Therapy: A Review of the Literature. Current Drug Metabolism 2021; 22(2): 89 doi: 10.2174/1389200221999201214224126
|
| 4 |
Gabrielle Vieyres, Thomas Pietschmann. Entry and replication of recombinant hepatitis C viruses in cell culture. Methods 2013; 59(2): 233 doi: 10.1016/j.ymeth.2012.09.005
|
| 5 |
Nihar Shah, Tracey Pierce, Kris V Kowdley. Review of direct-acting antiviral agents for the treatment of chronic hepatitis C. Expert Opinion on Investigational Drugs 2013; 22(9): 1107 doi: 10.1517/13543784.2013.806482
|
| 6 |
Jin-Hua Sun, Donald R. O'Boyle II, Yan Zhang, Chunfu Wang, Peter Nower, Lourdes Valera, Susan Roberts, Richard E. Nettles, Robert A. Fridell, Min Gao. Impact of a baseline polymorphism on the emergence of resistance to the hepatitis C virus nonstructural protein 5a replication complex inhibitor, BMS-790052. Hepatology 2012; 55(6): 1692 doi: 10.1002/hep.25581
|
| 7 |
Corina Rotărescu, Hannah Juárez- Solís , Ion Mărunțelu . CHRONIC HEPATITIS C VIRUS INFECTION: IS IT STILL A CHALLENGE?. Romanian Archives of Microbiology and Immunology 2022; 81(4): 278 doi: 10.54044/RAMI.2022.04.05
|
| 8 |
Esmaeil Behmard, Hussein T. Abdulabbas, Saade Abdalkareem Jasim, Sohrab Najafipour, Abdolmajid Ghasemian, Akbar Farjadfar, Ebrahim Barzegari, Amin Kouhpayeh, Parviz Abdolmaleki, Manas Ranjan Dikhit. Design of a novel multi-epitope vaccine candidate against hepatitis C virus using structural and nonstructural proteins: An immunoinformatics approach. PLOS ONE 2022; 17(8): e0272582 doi: 10.1371/journal.pone.0272582
|
| 9 |
Mustafa Altindis, Tuba Dal, Isin Akyar, Onur Karatuna, Selma Gokahmetoglu, Seda Tezcan Ulger, Canan Kulah, Berrin Uzun, Aslı Gamze Şener, Mehmet Ozdemir, Sibel Aydogan, Mert Ahmet Kuskucu, Kenan Midilli, Baris Otlu, Mustafa Kemal Celen, Kurtulus Buruk, Huseyin Guducuoglu. Six-year distribution pattern of hepatitis C virus in Turkey: a multicentre study. Biotechnology & Biotechnological Equipment 2016; 30(2): 335 doi: 10.1080/13102818.2015.1093430
|
| 10 |
Lokesh P. Tripathi, Chikako Kataoka, Shuhei Taguwa, Kohji Moriishi, Yoshio Mori, Yoshiharu Matsuura, Kenji Mizuguchi. Network based analysis of hepatitis C virus Core and NS4B protein interactions. Molecular BioSystems 2010; 6(12): 2539 doi: 10.1039/c0mb00103a
|
| 11 |
|
| 12 |
|
| 13 |
Iman Jamhiri, Khashayar Shahin, Zahra Khodabandeh, Kurosh Kalantar, Jamal Sarvari, Amir Atapour, Fatemeh Mina, Asma Ahmadnejad, Seyed Younes Hosseini. Recombinant NS3 Protein Induced Expression of Immune Modulatory Elements in Hepatic Stellate Cells During Its Fibrotic Activity. Viral Immunology 2018; 31(8): 575 doi: 10.1089/vim.2018.0018
|
| 14 |
José Abel Fernández Romero, María Gabriela Paglini, Christine Priano, Adolfina Koroch, Yoel Rodríguez, James Sailer, Natalia Teleshova. Algal and Cyanobacterial Lectins and Their Antimicrobial Properties. Marine Drugs 2021; 19(12): 687 doi: 10.3390/md19120687
|
| 15 |
Rachel S. Fogel, Catherine A. Chappell. Hepatitis C Virus in Pregnancy. Obstetrics and Gynecology Clinics of North America 2023; 50(2): 363 doi: 10.1016/j.ogc.2023.02.008
|
| 16 |
Jacqueline G. O’Leary, Gary L. Davis. Sleisenger and Fordtran's Gastrointestinal and Liver Disease. 2010; : 1313 doi: 10.1016/B978-1-4160-6189-2.00079-2
|
| 17 |
Ramesh Kakarla, Jian Liu, Devan Naduthambi, Wonsuk Chang, Ralph T. Mosley, Donghui Bao, Holly M. Micolochick Steuer, Meg Keilman, Shalini Bansal, Angela M. Lam, William Seibel, Sandra Neilson, Phillip A. Furman, Michael J. Sofia. Discovery of a Novel Class of Potent HCV NS4B Inhibitors: SAR Studies on Piperazinone Derivatives. Journal of Medicinal Chemistry 2014; 57(5): 2136 doi: 10.1021/jm4012643
|
| 18 |
Fernando González-Candelas, F Xavier López-Labrador. Clinical relevance of genetic heterogeneity in HCV. Future Virology 2010; 5(1): 33 doi: 10.2217/fvl.09.63
|
| 19 |
B. J. Thomson. Hepatitis C virus: the growing challenge. British Medical Bulletin 2008; 89(1): 153 doi: 10.1093/bmb/ldp003
|
| 20 |
Andrea Galli, Jens Bukh. Viral Fitness and Evolution. Current Topics in Microbiology and Immunology 2023; 439: 237 doi: 10.1007/978-3-031-15640-3_7
|
| 21 |
Ryota Masuzaki, Haruhiko Yoshida, Naoya Kato, Masao Omata. Hepatocellular Carcinoma. 2009; : 259 doi: 10.1007/978-1-60327-376-3_8
|
| 22 |
Michael Murray. Mechanisms and Clinical Significance of Pharmacokinetic Drug Interactions Mediated by FDA and EMA-approved Hepatitis C Direct-Acting Antiviral Agents. Clinical Pharmacokinetics 2023; 62(10): 1365 doi: 10.1007/s40262-023-01302-x
|
| 23 |
Rodrigo Velázquez-Moctezuma, Elias H. Augestad, Matteo Castelli, Christina Holmboe Olesen, Nicola Clementi, Massimo Clementi, Nicasio Mancini, Jannick Prentoe. Mechanisms of Hepatitis C Virus Escape from Vaccine-Relevant Neutralizing Antibodies. Vaccines 2021; 9(3): 291 doi: 10.3390/vaccines9030291
|
| 24 |
Gustavo Tavares Ventura, Emmerson Corrêa Brasil da Costa, Anne Miranda Capaccia, Ronaldo Mohana-Borges, Xi Zhou. pH-Dependent Conformational Changes in the HCV NS3 Protein Modulate Its ATPase and Helicase Activities. PLoS ONE 2014; 9(12): e115941 doi: 10.1371/journal.pone.0115941
|
| 25 |
M. Dominguez‐Villar, F. J. Garcia‐Cozar, B. J. Chambers. The Effects of Hepatitis C Virus Core Protein on Functional Responses in the NK Cell Line YTS. Scandinavian Journal of Immunology 2012; 75(1): 54 doi: 10.1111/j.1365-3083.2011.02624.x
|
| 26 |
Sara Abouelasrar Salama, Mieke Gouwy, Alexandra De Zutter, Noëmie Pörtner, Lotte Vanbrabant, Nele Berghmans, Mieke De Buck, Sofie Struyf, Jo Van Damme. Induction of Chemokines by Hepatitis C Virus Proteins: Synergy of the Core Protein with Interleukin-1β and Interferon-γ in Liver Bystander Cells. Journal of Interferon & Cytokine Research 2020; 40(4): 195 doi: 10.1089/jir.2019.0115
|
| 27 |
Elrashdy M. Redwan, Abdullah A. Aljadawi, Vladimir N. Uversky. Hepatitis C Virus Infection and Intrinsic Disorder in the Signaling Pathways Induced by Toll-Like Receptors. Biology 2022; 11(7): 1091 doi: 10.3390/biology11071091
|
| 28 |
Xiaohong Hou, Wengang Yang, Yongsen Zhao, Atul Agarwal, Mingjun Huang. Internal cleavages of hepatitis C virus NS3 induced by P1 mutations at the NS3/4A cleavage site. Virology 2009; 383(2): 271 doi: 10.1016/j.virol.2008.10.037
|
| 29 |
Yun Sik Hwang, Byeong Joo Jun, Tae Seon Yoon. Analysis of HCV’s Linearity Using Support Vector Machine (SVM). Applied Mechanics and Materials 2014; : 1265 doi: 10.4028/www.scientific.net/AMM.548-549.1265
|
| 30 |
Lei Shi, Shu-lin Zhang, Kang Li, Yuan Hong, Qi Wang, Yue Li, Jiang Guo, Wan-hu Fan, Lei Zhang, Jun Cheng. NS5ATP9, a gene up-regulated by HCV NS5A protein. Cancer Letters 2008; 259(2): 192 doi: 10.1016/j.canlet.2007.10.029
|
| 31 |
Zhengkun Tu, Robert H. Pierce, Jonathan Kurtis, Yoshio Kuroki, I. Nicholas Crispe, Mark S. Orloff. Hepatitis C Virus Core Protein Subverts the Antiviral Activities of Human Kupffer Cells. Gastroenterology 2010; 138(1): 305 doi: 10.1053/j.gastro.2009.09.009
|
| 32 |
Gyongyi Szabo, Angela Dolganiuc. Hepatitis C core protein – The “core” of immune deception?. Journal of Hepatology 2008; 48(1): 8 doi: 10.1016/j.jhep.2007.10.005
|
| 33 |
M Carrozzo. Oral diseases associated with hepatitis C virus infection. Part 1. sialadenitis and salivary glands lymphoma. Oral Diseases 2008; 14(2): 123 doi: 10.1111/j.1601-0825.2007.01436.x
|
| 34 |
Alessia Bianchi, Stefania Crotta, Michela Brazzoli, Steven K. H. Foung, Marcello Merola. Hepatitis C Virus E2 Protein Ectodomain Is Essential for Assembly of Infectious Virions. International Journal of Hepatology 2011; 2011: 1 doi: 10.4061/2011/968161
|
| 35 |
Małgorzata Rychłowska, Ania M. Owsianka, Steven K. H. Foung, Jean Dubuisson, Krystyna Bieńkowska-Szewczyk, Arvind H. Patel. Comprehensive linker-scanning mutagenesis of the hepatitis C virus E1 and E2 envelope glycoproteins reveals new structure–function relationships.
Journal of General Virology
2011; 92(10): 2249 doi: 10.1099/vir.0.034314-0
|
| 36 |
Mireille Baltzinger, Kamal Kant Sharma, Yves Mély, Danièle Altschuh. Dissecting the oligonucleotide binding properties of a disordered chaperone protein using surface plasmon resonance. Nucleic Acids Research 2013; 41(22): 10414 doi: 10.1093/nar/gkt792
|
| 37 |
Qiaoling Gong, Min Cheng, Hui Chen, Xiuying Liu, Youhui Si, Yang Yang, Yanzhi Yuan, Chaozhi Jin, Wei Yang, Fuchu He, Jian Wang. Phospholipid scramblase 1 mediates hepatitis C virus entry into host cells. FEBS Letters 2011; 585(17): 2647 doi: 10.1016/j.febslet.2011.07.019
|
| 38 |
Xiao Fan, Bin Xue, Patrick T. Dolan, Douglas J. LaCount, Lukasz Kurgan, Vladimir N. Uversky. The intrinsic disorder status of the human hepatitis C virus proteome. Mol. BioSyst. 2014; 10(6): 1345 doi: 10.1039/C4MB00027G
|
| 39 |
Ping‐Hung Ko, Chih‐Wei Tseng, Kuo‐Chih Tseng, Yen‐Chun Chen, Ching‐Sheng Hsu. The utility of HCV core antigen for evaluation of viremia at 48 weeks posttreatment with direct‐acting antivirals. Advances in Digestive Medicine 2023; 10(2): 80 doi: 10.1002/aid2.13316
|
| 40 |
Ahmad Abu Turab Naqvi, Farah Anjum, Alaa Shafie, Sufian Badar, Abdelbaset Mohamed Elasbali, Dharmendra Kumar Yadav, Md. Imtaiyaz Hassan, Timir Tripathi. Investigating host-virus interaction mechanism and phylogenetic analysis of viral proteins involved in the pathogenesis. PLOS ONE 2021; 16(12): e0261497 doi: 10.1371/journal.pone.0261497
|
| 41 |
Adrián Plata, Alberto Fernández‐Tejada. Carbohydrate‐Based Therapeutics. 2023; : 73 doi: 10.1002/9783527831326.ch3
|
| 42 |
Vladimir N. Uversky. Fight fire with fire: the need for a vaccine based on intrinsic disorder and structural flexibility. Exploration of Immunology 2022; 2(5): 731 doi: 10.37349/ei.2022.00079
|
| 43 |
Manish Dwivedi, Aditya Dwivedi, Debalina Mukherjee. An Insight into Hepatitis C Virus: In Search of Promising Drug Targets. Current Drug Targets 2023; 24(14): 1127 doi: 10.2174/0113894501265769231020031857
|
| 44 |
Feng Ni, Smitha Kota, Virginia Takahashi, A. Donny Strosberg, John K. Snyder. Potent inhibitors of hepatitis C core dimerization as new leads for anti-hepatitis C agents. Bioorganic & Medicinal Chemistry Letters 2011; 21(8): 2198 doi: 10.1016/j.bmcl.2011.03.014
|
| 45 |
Sergey A. Shiryaev, Andrei V. Chernov, Tatiana N. Shiryaeva, Alexander E. Aleshin, Alex Y. Strongin. The acidic sequence of the NS4A cofactor regulates ATP hydrolysis by the HCV NS3 helicase. Archives of Virology 2011; 156(2): 313 doi: 10.1007/s00705-010-0838-2
|
| 46 |
Morgan M. Martin, Stephanie A. Condotta, Jeremy Fenn, Andrea D. Olmstead, François Jean. In-cell selectivity profiling of membrane-anchored and replicase-associated hepatitis C virus NS3-4A protease reveals a common, stringent substrate recognition profile. Biological Chemistry 2011; 392(10): 927 doi: 10.1515/BC.2011.076
|
| 47 |
Ahmed Abd El-Aleem Abue El-Hassan, Mohamed Gaber Abdallah, Mohammed Mohammed Azab, Tarek A. Hassan, Abd-ElHameed Atta, Mohamed Abdelhamed Elsawy, Mabrouk M. AboElenin. Architect HCV Ag assay is an efficient alternative tool to RNA qRT-PCR quantification for assessing viral load in HCV infection. The Scientific Journal of Al-Azhar Medical Faculty, Girls 2021; 5(2): 494 doi: 10.4103/sjamf.sjamf_94_21
|
| 48 |
Catherine Fauvelle, Quentin Lepiller, Daniel J. Felmlee, Isabel Fofana, François Habersetzer, Françoise Stoll-Keller, Thomas F. Baumert, Samira Fafi-Kremer. Hepatitis C virus vaccines – Progress and perspectives. Microbial Pathogenesis 2013; 58: 66 doi: 10.1016/j.micpath.2013.02.005
|
| 49 |
F. Poordad, D. Dieterich. Treating hepatitis C: current standard of care and emerging direct‐acting antiviral agents. Journal of Viral Hepatitis 2012; 19(7): 449 doi: 10.1111/j.1365-2893.2012.01617.x
|
| 50 |
Anoop Kumar, Roma Pandey, Inderjit S. Yadav, Mausumi Bharadwaj. Structural and Epitope Analysis (T- and B-Cell Epitopes) of Hepatitis C Virus (HCV) Glycoproteins: An in silico Approach. Journal of Clinical and Experimental Hepatology 2018; 8(4): 352 doi: 10.1016/j.jceh.2017.12.010
|
| 51 |
Eve-Isabelle Pécheur. Lipoprotein Receptors and Lipid Enzymes in Hepatitis C Virus Entry and Early Steps of Infection. Scientifica 2012; 2012: 1 doi: 10.6064/2012/709853
|
| 52 |
Ja Yeon Kim Chu, Jing-hsiung James Ou. Autophagy in HCV Replication and Protein Trafficking. International Journal of Molecular Sciences 2021; 22(3): 1089 doi: 10.3390/ijms22031089
|
| 53 |
John Carl Hoefs, Vikramjit S. Aulakh, Bernard Joseph Ilagan. Very Low Viral Load (VLVL) Relapse Following Treatment of Naïve Patients with Chronic Hepatitis C. Digestive Diseases and Sciences 2012; 57(1): 243 doi: 10.1007/s10620-011-1973-7
|
| 54 |
Luis A Bernal, Varun Soti. Hepatitis C Virus: Insights Into Its History, Treatment, Challenges, and Future Directions. Cureus 2023; doi: 10.7759/cureus.43924
|
| 55 |
Dae-Sun Kim, Young-Joo Cho, Byoung-Guk Kim, Su-Hae Lee, Jae-Hwan Nam. Systematic analysis of attenuated Coxsackievirus expressing a foreign gene as a viral vaccine vector. Vaccine 2010; 28(5): 1234 doi: 10.1016/j.vaccine.2009.11.017
|
| 56 |
Jiarui Li, Ester Boix. Host Defence RNases as Antiviral Agents against Enveloped Single Stranded RNA Viruses. Virulence 2021; 12(1): 444 doi: 10.1080/21505594.2021.1871823
|
| 57 |
Konstantina Katsarou, Panagiota Tsitoura, Urania Georgopoulou. MEK5/ERK5/mef2: A novel signaling pathway affected by hepatitis C virus non-enveloped capsid-like particles. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 2011; 1813(10): 1854 doi: 10.1016/j.bbamcr.2011.06.015
|
| 58 |
Leila Kasraian, Ali Farhadi, Gholamreza Rafiei Dehbidi, Mehdi Mirzakhani, Sedigheh Sharifzadeh, Sepide Namdari, Abbas Behzad-Behbahani. Comparing RT-qPCR and Hepatitis C Virus Antigen Detection Assay for Detecting Active Infection in Blood Donors in Fars Province, Iran. Hepatitis Monthly 2022; 22(1) doi: 10.5812/hepatmon-123438
|
| 59 |
Narotam Narotam. Characterization of Hepatitis C Virus (HCV) Genotypes with Spectrum of its Viral Load. Journal of Analytical & Pharmaceutical Research 2016; 3(3) doi: 10.15406/japlr.2016.03.00058
|
| 60 |
Kazem Baesi, Ali Akbar Velayati, Masoumeh Farrokh Ashtiani, Kamal Fakhredini, Mohammad Banifazl, Mona Sadat Larijani, Parya Basimi, Amitis Ramezani. Prevalence of Naturally Occurring Resistance Associated Substitutions in NS3/4AProtease Inhibitors in Iranian HCV/HIV Infected Patients. Current HIV Research 2021; 19(5): 391 doi: 10.2174/1566523221666210707142838
|
| 61 |
John Paul Pezacki, Ragunath Singaravelu, Rodney K. Lyn. Host–virus interactions during hepatitis C virus infection: a complex and dynamic molecular biosystem. Molecular BioSystems 2010; 6(7): 1131 doi: 10.1039/b924668c
|
| 62 |
Reem Al Olaby, Hassan M. Azzazy, Rodney Harris, Brett Chromy, Jost Vielmetter, Rod Balhorn. Identification of ligands that target the HCV-E2 binding site on CD81. Journal of Computer-Aided Molecular Design 2013; 27(4): 337 doi: 10.1007/s10822-013-9649-3
|
| 63 |
Putu Yuliandari, Chieko Matsui, Lin Deng, Takayuki Abe, Hiroyuki Mori, Shuhei Taguwa, Chikako Ono, Takasuke Fukuhara, Yoshiharu Matsuura, Ikuo Shoji. Hepatitis C virus NS5A protein promotes the lysosomal degradation of diacylglycerol O-acyltransferase 1 (DGAT1) via endosomal microautophagy. Autophagy Reports 2022; 1(1): 264 doi: 10.1080/27694127.2022.2095591
|
| 64 |
Hyock Joo Kwon, Weimei Xing, Katie Chan, Anita Niedziela-Majka, Katherine M. Brendza, Thorsten Kirschberg, Darryl Kato, John O. Link, Guofeng Cheng, Xiaohong Liu, Roman Sakowicz, Philippe A. Gallay. Direct Binding of Ledipasvir to HCV NS5A: Mechanism of Resistance to an HCV Antiviral Agent. PLOS ONE 2015; 10(4): e0122844 doi: 10.1371/journal.pone.0122844
|
| 65 |
Howard E. Boudreau, Suzanne U. Emerson, Agnieszka Korzeniowska, Meghan A. Jendrysik, Thomas L. Leto. Hepatitis C Virus (HCV) Proteins Induce NADPH Oxidase 4 Expression in a Transforming Growth Factor β-Dependent Manner: a New Contributor to HCV-Induced Oxidative Stress. Journal of Virology 2009; 83(24): 12934 doi: 10.1128/JVI.01059-09
|
| 66 |
Kaartik Soota, Benedict Maliakkal. Ribavirin induced hemolysis: A novel mechanism of action against chronic hepatitis C virus infection. World Journal of Gastroenterology 2014; 20(43): 16184-16190 doi: 10.3748/wjg.v20.i43.16184
|
| 67 |
Ryota Masuzaki, Tatsuo Kanda, Haruhiko Yoshida, Naoya Kato, Masao Omata. Hepatocellular Carcinoma. 2016; : 261 doi: 10.1007/978-3-319-34214-6_17
|
| 68 |
Ameer Abutaleb, Shyam Kottilil, Elana Rosenthal. Viral Infections of Humans. 2022; : 1 doi: 10.1007/978-1-4939-9544-8_64-1
|
| 69 |
V. E. Gurtsevitch. Human oncogenic viruses: Hepatitis B and hepatitis C viruses and their role in hepatocarcinogenesis. Biochemistry (Moscow) 2008; 73(5): 504 doi: 10.1134/S0006297908050039
|
| 70 |
Cristina Simona Strahotin, Michael Babich. Hepatitis C Variability, Patterns of Resistance, and Impact on Therapy. Advances in Virology 2012; 2012: 1 doi: 10.1155/2012/267483
|
| 71 |
Ming-Ju Hsieh, Kuang-Ping Lan, Hao-Yu Liu, Xiao-Zong Zhang, Yaw-Feng Lin, Tzy-Yen Chen, Hui-Ling Chiou. Hepatitis C virus E2 protein involve in insulin resistance through an impairment of Akt/PKB and GSK3β signaling in hepatocytes. BMC Gastroenterology 2012; 12(1) doi: 10.1186/1471-230X-12-74
|
| 72 |
Huirong Zhang, Subash C. B. Gopinath. Gold-aptamer modified dielectrode silica surface for hepatitis C virus core antigen sandwich assay. Materials Express 2023; 13(2): 267 doi: 10.1166/mex.2023.2348
|
| 73 |
Sergey A. Shiryaev, Elliot R. Thomsen, Piotr Cieplak, Eugene Chudin, Anton V. Cheltsov, Mark S. Chee, Igor A. Kozlov, Alex Y. Strongin, Tianyi Wang. New Details of HCV NS3/4A Proteinase Functionality Revealed by a High-Throughput Cleavage Assay. PLoS ONE 2012; 7(4): e35759 doi: 10.1371/journal.pone.0035759
|
| 74 |
Feng He, Sangeeta B. Joshi, Fons Bosman, Marijke Verhaeghe, C. Russell Middaugh. Structural stability of hepatitis C virus envelope glycoprotein E1: Effect of pH and dissociative detergents. Journal of Pharmaceutical Sciences 2009; 98(9): 3340 doi: 10.1002/jps.21657
|
| 75 |
Lokesh P. Tripathi, Hiroto Kambara, Yi-An Chen, Yorihiro Nishimura, Kohji Moriishi, Toru Okamoto, Eiji Morita, Takayuki Abe, Yoshio Mori, Yoshiharu Matsuura, Kenji Mizuguchi. Understanding the Biological Context of NS5A–Host Interactions in HCV Infection: A Network-Based Approach. Journal of Proteome Research 2013; 12(6): 2537 doi: 10.1021/pr3011217
|
| 76 |
Sarah Welbourn, Arnim Pause. HCV NS2/3 protease: a future antiviral drug target?. Future Virology 2009; 4(5): 463 doi: 10.2217/fvl.09.29
|
| 77 |
Michael A. Nalesnik, Tatsuya Kanto. Natural Killer Cells. 2010; : 571 doi: 10.1016/B978-0-12-370454-2.00044-2
|
| 78 |
Birke Andrea Tews, Anne Klingebeil, Juliane Kühn, Kati Franzke, Till Rümenapf, Gregor Meyers. The Erns Carboxyterminus: Much More Than a Membrane Anchor. Viruses 2021; 13(7): 1203 doi: 10.3390/v13071203
|
| 79 |
Sobia Manzoor, Madiha Khalid, Muhammad Idrees, Usman Ali Ashfaq. P2X4 receptors mediate induction of antioxidants, fibrogenic cytokines and ECM transcripts; in presence of replicating HCV in in vitro setting: An insight into role of P2X4 in fibrosis. PLOS ONE 2022; 17(5): e0259727 doi: 10.1371/journal.pone.0259727
|
| 80 |
Irene Boo, Kevin teWierik, Florian Douam, Dimitri Lavillette, Pantelis Poumbourios, Heidi E. Drummer. Distinct roles in folding, CD81 receptor binding and viral entry for conserved histidine residues of hepatitis C virus glycoprotein E1 and E2. Biochemical Journal 2012; 443(1): 85 doi: 10.1042/BJ20110868
|
| 81 |
Brendan A. Palmer, Liam J. Fanning, Tamir Tuller. Synonymous Co-Variation across the E1/E2 Gene Junction of Hepatitis C Virus Defines Virion Fitness. PLOS ONE 2016; 11(11): e0167089 doi: 10.1371/journal.pone.0167089
|
| 82 |
William M. Kamp, Cortlandt M. Sellers, Stacey Stein, Joseph K. Lim, Hyun S. Kim. Impact of Direct Acting Antivirals on Survival in Patients with Chronic Hepatitis C and Hepatocellular Carcinoma. Scientific Reports 2019; 9(1) doi: 10.1038/s41598-019-53051-2
|
| 83 |
V. E. Ekushov, A. V. Totmenin, L. G. Gotfrid, M. R. Halikov, V.-V. V. Minikhanova, S. E. Skudarnov, T. S. Ostapova, N. M. Gashnikova. Genetic diversity of hepatitis C virus and the prevalence of resistance mutations to NS5A inhibitors in the Krasnoyarsk region. South of Russia: ecology, development 2024; 19(1): 47 doi: 10.18470/1992-1098-2024-1-4
|
| 84 |
Arthi Venkatesan, Febin Prabhu Dass J.. Review on chemogenomic approaches towards hepatitis C viral targets. Journal of Cellular Biochemistry 2019; 120(8): 12167 doi: 10.1002/jcb.28581
|
| 85 |
Raewyn M. Poole. Daclatasvir + Asunaprevir: First Global Approval. Drugs 2014; 74(13): 1559 doi: 10.1007/s40265-014-0279-4
|
| 86 |
Clement I. Mboto, Uwem O. Edet, Elizabeth N. Mbim, Wilfred O. Ndifon, Eno E. Ebenso, Henry O. Egharevba, Uwem E. George, Francisca O. Nwaokorie, Samuel.I. Udo. In- silico evaluation of bioactive compounds from selected medicinal plants from Southern Nigeria against hepatitis C virus genotype 1 RNA-directed RNA polymerase. Scientific African 2023; 22: e01919 doi: 10.1016/j.sciaf.2023.e01919
|
| 87 |
Ulrike Breitinger, Noha S. Farag, Nourhan K. M. Ali, Marwa Ahmed, Mohamed A. El-Azizi, Hans-Georg Breitinger. Cell viability assay as a tool to study activity and inhibition of hepatitis C p7 channels. Journal of General Virology 2021; 102(3) doi: 10.1099/jgv.0.001571
|
| 88 |
Jillian Whidby, Guaniri Mateu, Hannah Scarborough, Borries Demeler, Arash Grakoui, Joseph Marcotrigiano. Blocking Hepatitis C Virus Infection with Recombinant Form of Envelope Protein 2 Ectodomain. Journal of Virology 2009; 83(21): 11078 doi: 10.1128/JVI.00800-09
|
| 89 |
Chul Hyun Joo, Uk Lee, Young Ran Nam, Jae U. Jung, Heuiran Lee, Young Keol Cho, Yoo Kyum Kim. Gene Therapeutic Approach for Inhibiting Hepatitis C Virus Replication Using a Recombinant Protein That Controls Interferon Expression. Antimicrobial Agents and Chemotherapy 2010; 54(12): 5048 doi: 10.1128/AAC.00682-10
|
| 90 |
Corlan O Adebajo, Nancy Reau. Overtreating versus undertreating: what is the optimized treatment duration in HCV?. Future Virology 2015; 10(9): 1049 doi: 10.2217/fvl.15.71
|
| 91 |
Dennis Özcelik, Andrew Seto, Bojana Rakic, Ali Farzam, Frantisek Supek, John Paul Pezacki. Gene Expression Profiling of Endoplasmic Reticulum Stress in Hepatitis C Virus-Containing Cells Treated with an Inhibitor of Protein Disulfide Isomerases. ACS Omega 2018; 3(12): 17227 doi: 10.1021/acsomega.8b02676
|
| 92 |
Xiaoli Pang, Zhaoxia Wang, Naicui Zhai, Qianqian Zhang, Hongxiao Song, Yujiao Zhang, Tianyang Li, Haijun Li, Lishan Su, Junqi Niu, Zhengkun Tu. IL-10 plays a central regulatory role in the cytokines induced by hepatitis C virus core protein and polyinosinic acid:polycytodylic acid. International Immunopharmacology 2016; 38: 284 doi: 10.1016/j.intimp.2016.06.013
|
| 93 |
Regina Maria Santos de Amorim, Alexandre Coelho, Elisabeth Lampe, Tainá Raiol, Regina Maria Bringel Martins. Genetic diversity of hepatitis C virus quasispecies in chronic renal failure patients in Midwest Brazil. Archives of Virology 2014; 159(8): 1917 doi: 10.1007/s00705-014-1994-6
|
| 94 |
Markus Reiser, Jörg Timm. Serine protease inhibitors as anti-hepatitis C virus agents. Expert Review of Anti-infective Therapy 2009; 7(5): 537 doi: 10.1586/eri.09.30
|
| 95 |
Jacqueline G. O'Leary, Gary L. Davis. Review: Hepatitis C virus replication and potential targets for direct-acting agents. Therapeutic Advances in Gastroenterology 2010; 3(1): 43 doi: 10.1177/1756283X09353353
|
| 96 |
Lucie Goueslain, Khaled Alsaleh, Pauline Horellou, Philippe Roingeard, Véronique Descamps, Gilles Duverlie, Yann Ciczora, Czeslaw Wychowski, Jean Dubuisson, Yves Rouillé. Identification of GBF1 as a Cellular Factor Required for Hepatitis C Virus RNA Replication. Journal of Virology 2010; 84(2): 773 doi: 10.1128/JVI.01190-09
|
| 97 |
Martin Coenen, Hans Dieter Nischalke, Benjamin Krämer, Bettina Langhans, Andreas Glässner, Daniela Schulte, Christian Körner, Tilman Sauerbruch, Jacob Nattermann, Ulrich Spengler. Hepatitis C virus core protein induces fibrogenic actions of hepatic stellate cells via toll-like receptor 2. Laboratory Investigation 2011; 91(9): 1375 doi: 10.1038/labinvest.2011.78
|
| 98 |
Samuel K. Kwofie, Ulf Schaefer, Vijayaraghava S. Sundararajan, Vladimir B. Bajic, Alan Christoffels. HCVpro: Hepatitis C virus protein interaction database. Infection, Genetics and Evolution 2011; 11(8): 1971 doi: 10.1016/j.meegid.2011.09.001
|
| 99 |
Roberta Spadaccini, Gerardino D'Errico, Viviana D'Alessio, Eugenio Notomista, Alessia Bianchi, Marcello Merola, Delia Picone. Structural characterization of the transmembrane proximal region of the hepatitis C virus E1 glycoprotein. Biochimica et Biophysica Acta (BBA) - Biomembranes 2010; 1798(3): 344 doi: 10.1016/j.bbamem.2009.10.018
|
| 100 |
Weifeng Shi, Ines T. Freitas, Chaodong Zhu, Wei Zheng, William W. Hall, Desmond G. Higgins, John E. Tavis. Recombination in Hepatitis C Virus: Identification of Four Novel Naturally Occurring Inter-Subtype Recombinants. PLoS ONE 2012; 7(7): e41997 doi: 10.1371/journal.pone.0041997
|
| 101 |
Flavia Bernini, Erika Ebranati, Chiara De Maddalena, Renata Shkjezi, Laura Milazzo, Alessandra Lo Presti, Massimo Ciccozzi, Massimo Galli, Gianguglielmo Zehender, John Tavis. Within-Host Dynamics of the Hepatitis C Virus Quasispecies Population in HIV-1/HCV Coinfected Patients. PLoS ONE 2011; 6(1): e16551 doi: 10.1371/journal.pone.0016551
|
| 102 |
David Wyles, Alessandra Mangia, Wendy Cheng, Stephen Shafran, Christian Schwabe, Wen Ouyang, Charlotte Hedskog, John McNally, Diana M Brainard, Brian P Doehle, Evguenia Svarovskaia, Michael D Miller, Hongmei Mo, Hadas Dvory-Sobol. Long-Term Persistence of HCV NS5A Resistance-Associated Substitutions after Treatment with the HCV NS5A Inhibitor, Ledipasvir, without Sofosbuvir. Antiviral Therapy 2018; 23(3): 229 doi: 10.3851/IMP3181
|
| 103 |
Developments in the HCV Screening Technologies Based on the Detection of Antigens and Antibodies. Sensors 2019; 19(19): 4257 doi: 10.3390/s19194257
|
| 104 |
Christopher J. Mee, Michelle J. Farquhar, Helen J. Harris, Ke Hu, Wenda Ramma, Asif Ahmed, Patrick Maurel, Roy Bicknell, Peter Balfe, Jane A. McKeating. Hepatitis C Virus Infection Reduces Hepatocellular Polarity in a Vascular Endothelial Growth Factor–Dependent Manner. Gastroenterology 2010; 138(3): 1134 doi: 10.1053/j.gastro.2009.11.047
|
| 105 |
Maemu Petronella Gededzha, M. Jeffrey Mphahlele, Jason T. Blackard, Selokela Gloria Selabe. Prevalence of NS5B Resistance Mutations in Hepatitis C Virus (HCV) Treatment Naive South Africans. Hepatitis Monthly 2017; 17(6) doi: 10.5812/hepatmon.14248
|
| 106 |
Arthur Donny Strosberg, Smitha Kota, Virginia Takahashi, John K. Snyder, Guillaume Mousseau. Core as a Novel Viral Target for Hepatitis C Drugs. Viruses 2010; 2(8): 1734 doi: 10.3390/v2081734
|
| 107 |
Ulrike Breitinger, Noha S. Farag, Nourhan K.M. Ali, Hans-Georg A. Breitinger. Patch-Clamp Study of Hepatitis C p7 Channels Reveals Genotype-Specific Sensitivity to Inhibitors. Biophysical Journal 2016; 110(11): 2419 doi: 10.1016/j.bpj.2016.04.018
|
| 108 |
Tomohiko Maehama, Masayoshi Fukasawa, Tomoko Date, Takaji Wakita, Kentaro Hanada. A class II phosphoinositide 3-kinase plays an indispensable role in hepatitis C virus replication. Biochemical and Biophysical Research Communications 2013; 440(1): 150 doi: 10.1016/j.bbrc.2013.09.048
|
| 109 |
Heidi Barth, Eric Robinet, T. Jake Liang, Thomas F. Baumert. Mouse models for the study of HCV infection and virus–host interactions. Journal of Hepatology 2008; 49(1): 134 doi: 10.1016/j.jhep.2008.03.012
|
| 110 |
Yaqi Yu, Zhenzhou Wan, Jian-Hua Wang, Xianguang Yang, Chiyu Zhang. Review of human pegivirus: Prevalence, transmission, pathogenesis, and clinical implication. Virulence 2022; 13(1): 323 doi: 10.1080/21505594.2022.2029328
|
| 111 |
Giuseppe A Sautto, Karin Wisskirchen, Nicola Clementi, Matteo Castelli, Roberta A Diotti, Julia Graf, Massimo Clementi, Roberto Burioni, Ulrike Protzer, Nicasio Mancini. Chimeric antigen receptor (CAR)-engineered T cells redirected against hepatitis C virus (HCV) E2 glycoprotein. Gut 2016; 65(3): 512 doi: 10.1136/gutjnl-2014-308316
|
| 112 |
Oluwatoyin Campbell, Viviana Monje-Galvan. Lipid composition modulates interactions of p7 viroporin during membrane insertion. Journal of Structural Biology 2023; 215(3): 108013 doi: 10.1016/j.jsb.2023.108013
|
| 113 |
Andrew H. Talal, Yang Chen, Marija Zeremski, Roberto Zavala, Clewert Sylvester, Mary Kuhns, Lawrence S. Brown, Marianthi Markatou, Gavin A. Cloherty. Hepatitis C virus core antigen: A potential alternative to HCV RNA testing among persons with substance use disorders. Journal of Substance Abuse Treatment 2017; 78: 37 doi: 10.1016/j.jsat.2017.04.011
|
| 114 |
Zhiyan Yao, Xiaotian Song, Shiru Cao, Wenzhang Liang, Wenran Lu, Lijuan Yang, Zhengzheng Zhang, Lin Wei, Ratna B. Ray. Role of the Exogenous HCV Core Protein in the Interaction of Human Hepatocyte Proliferation and Macrophage Sub-Populations. PLoS ONE 2014; 9(9): e108278 doi: 10.1371/journal.pone.0108278
|
| 115 |
Lokesh P. Tripathi, Hiroto Kambara, Kohji Moriishi, Eiji Morita, Takayuki Abe, Yoshio Mori, Yi-An Chen, Yoshiharu Matsuura, Kenji Mizuguchi. Proteomic Analysis of Hepatitis C Virus (HCV) Core Protein Transfection and Host Regulator PA28γ Knockout in HCV Pathogenesis: A Network-Based Study. Journal of Proteome Research 2012; 11(7): 3664 doi: 10.1021/pr300121a
|
| 116 |
Heena Tarannum, Bhumika Chauhan, Asmita Samadder, Harekrishna Roy, Sisir Nandi. To Explore the Potential Targets and Current Structure-based Design Strategies Utilizing Co-crystallized Ligand to Combat HCV. Current Drug Targets 2021; 22(5): 590 doi: 10.2174/1389450121999200727215020
|
| 117 |
Ahmed Gaballah, Birke Bartosch. An Update on the Metabolic Landscape of Oncogenic Viruses. Cancers 2022; 14(23): 5742 doi: 10.3390/cancers14235742
|